X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Pharma Industry News - 27/Jun 15:06

PIK3CA Could Guide Use of COX-2 Inhibitors in Treatment for Colon Cancer

THURSDAY, June 27, 2024 -- PIK3CA mutational status may be beneficial for predicting response to addition of the cyclooxygenase 2 (COX-2) inhibitor celecoxib to standard adjuvant chemotherapy in stage III resected colon cancer, according to a study...

Articles similaires

Anti-inflammatory drug celecoxib could reduce risk of colon cancer recurrence for a subset of patients

oncologynews.com.au - 25/Jun 12:37

An analysis of data from a randomised clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...

Sorry! Image not available at this time

Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma

drugs.com - 24/Jun 15:03

MONDAY, June 24, 2024 -- For patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a...

Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy response

news.medical.net - 20/Jun 19:26

Because not all cancer patients respond to a leading type of cancer immunotherapy drug, known as an immune checkpoint inhibitor, scientists explored...

Exploring Breast Cancer Stages: A Guide to Understanding the Classification System

popdiaries.com - 28/Jun 11:43

Breast cancer is a complex disease with varying degrees of severity and treatment approaches. Central to understanding and managing breast cancer is...

New Strategy to Enhance Checkpoint Inhibitor Therapy for Cancer

medindia.net - 27/Jun 16:00

Introducing a novel approach to enhance checkpoint inhibitor therapy for cancer, promising improved treatment outcomes and efficacy in clinical...

Key Vascular Growth Factor in Cancer Treatment Identified

medindia.net - 29/Jun 19:41

Study identifies a pivotal vascular growth factor crucial for advancing colon and renal cancer treatments, offering promising avenues for medical...

New global research aims to improve survival rates for pancreatic cancer patients

oncologynews.com.au - 26/Jun 15:44

A new study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating...

Ultrasensitive liquid biopsy tech spots cancer earlier than standard methods

oncologynews.com.au - 25/Jun 13:12

An artificial intelligence-powered method for detecting tumour DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a...

Pre-Surgery Chemotherapy Benefits Pancreatic Cancer Patients

medindia.net - 21/Jun 09:50

Administering chemotherapy before surgery has shown benefits for select pancreatic cancer patients potentially improving treatment outcomes and...

Sorry! Image not available at this time

Combo Drug, Kadcyla, Boosts Survival in Some Women With Early Breast Cancer

drugs.com - 28/Jun 11:06

FRIDAY, June 28, 20204 (HealthDay news) -- An immunotherapy/chemotherapy combo drug can help early-stage breast cancer patients remain cancer-free...